Arterial hypertension assessed “out-of-office” in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated “white coat” phenomenon

[1]  R. Schmieder,et al.  Are physicians underestimating the challenges of hypertension management? Results from the Supporting Hypertension Awareness and Research Europe-wide (SHARE) survey , 2013, European journal of preventive cardiology.

[2]  Kunihiko Hayashi,et al.  Independent association between age at natural menopause and hypercholesterolemia, hypertension, and diabetes mellitus: Japan nurses' health study. , 2013, Journal of atherosclerosis and thrombosis.

[3]  K. Liao,et al.  Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis. , 2013, Rheumatology.

[4]  G. Kitas,et al.  Myocardial ischaemia without obstructive coronary artery disease in rheumatoid arthritis : hypothesis-generating insights from a cross-sectional study , 2012 .

[5]  Z. Yiğit,et al.  Central aortic blood pressure and augmentation index during normal pregnancy , 2012, Hypertension Research.

[6]  Janneke Tekstra,et al.  Low-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis , 2012, Annals of Internal Medicine.

[7]  M. Szklo,et al.  Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis. , 2012, Seminars in arthritis and rheumatism.

[8]  C. Turesson,et al.  Early menopause is an independent predictor of rheumatoid arthritis , 2011, Annals of the rheumatic diseases.

[9]  P. Sfikakis,et al.  A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis. , 2011, Atherosclerosis.

[10]  D. Carroll,et al.  Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis , 2011, Journal of Human Hypertension.

[11]  M. Szklo,et al.  Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis. , 2011, Arthritis and rheumatism.

[12]  J. Banegas,et al.  Abnormalities in ambulatory blood pressure monitoring in hypertensive patients with diabetes , 2011, Hypertension Research.

[13]  P. Sarafidis Epidemiology of Resistant Hypertension , 2011, Journal of clinical hypertension.

[14]  G. Stergiou,et al.  Automated determination of the ankle-brachial index using an oscillometric blood pressure monitor: validation vs. Doppler measurement and cardiovascular risk factor profile , 2011, Hypertension Research.

[15]  J. Olesen,et al.  Extended Report , 2022 .

[16]  S. Gabriel,et al.  Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives , 2010, Annals of the rheumatic diseases.

[17]  B Waeber,et al.  European Society of Hypertension Practice Guidelines for home blood pressure monitoring , 2010, Journal of Human Hypertension.

[18]  B. Dijkmans,et al.  Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial , 2010, Annals of the rheumatic diseases.

[19]  H. John,et al.  Target organ damage in patients with rheumatoid arthritis: the role of blood pressure and heart rate. , 2010, Atherosclerosis.

[20]  D. Symmons,et al.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis , 2009, Annals of the rheumatic diseases.

[21]  G. Kitas,et al.  Atherosclerosis in Rheumatoid Arthritis Versus Diabetes: A Comparative Study , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[22]  A. Nevill,et al.  Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[23]  J. Blacher,et al.  Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study. , 2009, Journal of the American College of Cardiology.

[24]  G. Kitas,et al.  Galectin-2 (LGALS2) 3279C/T Polymorphism may be Independently Associated with Diastolic Blood Pressure in Patients with Rheumatoid Arthritis , 2009, Clinical and experimental hypertension.

[25]  Mohsen Sadatsafavi,et al.  Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. , 2008, Arthritis and rheumatism.

[26]  G. Stergiou,et al.  Validation of the Microlife Watch BP Office professional device for office blood pressure measurement according to the International protocol , 2008, Blood pressure monitoring.

[27]  G. Kitas,et al.  Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis. , 2008, Rheumatology.

[28]  G. Kitas,et al.  Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis. , 2008, Endothelium : journal of endothelial cell research.

[29]  Antonios,et al.  Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. , 2007, Rheumatology.

[30]  A. Dominiczak,et al.  2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.

[31]  G. Stergiou,et al.  Validation of the Microlife WatchBP Home device for self home blood pressure measurement according to the International Protocol , 2007, Blood pressure monitoring.

[32]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[33]  D. Panagiotakos,et al.  Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore. , 2007, Preventive medicine.

[34]  E. Kulinskaya,et al.  Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. , 2006, Rheumatology.

[35]  K. Fotiadis,et al.  Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: the Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national study. , 2006, American journal of hypertension.

[36]  P. Palatini,et al.  Masked hypertension in adults , 2005, Blood pressure monitoring.

[37]  A. Naska,et al.  Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study. , 2004, International journal of epidemiology.

[38]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[39]  P. Sarafidis,et al.  Prevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa study , 2004, Journal of Human Hypertension.

[40]  D. Panagiotakos,et al.  Epidemiology of cardiovascular risk factors in Greece: aims, design and baseline characteristics of the ATTICA study , 2003, BMC public health.

[41]  D. Panagiotakos,et al.  Status and management of hypertension in Greece: role of the adoption of a Mediterranean diet the Attica study , 2003, Journal of hypertension.

[42]  D. Panagiotakos,et al.  Status and management of hypertension in Greece: role of the adoption of a Mediterranean diet , 2003 .

[43]  M. Tomšič,et al.  Leflunomide and hypertension , 2002, Annals of the rheumatic diseases.

[44]  G L Freeman,et al.  High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. , 2001, Arthritis and rheumatism.

[45]  G. Stergiou,et al.  Prevalence, awareness, treatment, and control of hypertension in Greece: the Didima study. , 1999, American journal of hypertension.

[46]  F. Mee,et al.  Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society protocol. , 1991, Journal of hypertension.

[47]  A. Silman,et al.  Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients. , 1990, Annals of the rheumatic diseases.

[48]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.